Your session is about to expire
← Back to Search
Laddr for Binge Eating
N/A
Waitlist Available
Led By Russell A Poldrack, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights
Study Summary
This study is evaluating whether self-regulation can be manipulated to help individuals with binge eating disorder.
Eligible Conditions
- Binge Eating
- Behavior
- Smoking
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 28 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Binge Eating Episodes - Loss of Control
Binge Eating Episodes - Overeating
Number of Cigarettes Smoked Per Day
Trial Design
2Treatment groups
Experimental Treatment
Group I: Smoking GroupExperimental Treatment1 Intervention
All participants in the study will be invited to use Laddr, described in the intervention section.
Group II: Binge Eating GroupExperimental Treatment1 Intervention
All participants in the study will be invited to use Laddr, described in the intervention section.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Laddr
2018
N/A
~1740
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,264 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,785 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,469 Previous Clinical Trials
2,619,318 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger